Excision BioTherapeutics Inc — Form D
Excision BioTherapeutics Inc of SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2021-02-22. The offering totals $63.8M, of which $60.7M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2021-02-22
- Form: D
- Accession: 0001847173-21-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $63.8M
- Amount sold: $60.7M
- Remaining: $3.0M
- Minimum investment: $1
- Investors: 32
- Date of first sale: 2021-02-03
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-390027
Issuer
- Name: Excision BioTherapeutics Inc
- CIK: 0001847173
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 988 MARKET STREET, SECOND FLOOR, SAN FRANCISCO, CA, 94102
- Phone: (404) 229-1162
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Ashok Krishnamurthi | Director | San Francisco, CA |
| Vasudev Bailey | Director | New Yoprk City, NY |
| William Carson | Director | Oakland, CA |
| Daniel Dornbusch | Director | San Francisco, CA |
| Daniel Dornbusch | Executive Officer | San Francisco, CA |
Other filings by this issuer (1)
More